The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

Add Yahoo as a preferred source to see more of our stories on Google. Alzheimer's disease, the most common form of dementia, is responsible for tens of millions of cases around the world. Jens Kalaene ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

“Stories of Hope” shares the stories of the people and scientists at the forefront of advancing medical science and pushing ...

A new study found that fixing energy balance in the brain reversed symptoms of advanced Alzheimer’s in mice.  Researchers used a drug (P7C3-A20) to ...

Memorial Sloan Kettering Cancer Center's mission is to end cancer. To get there, the famed organization must keep improving clinical care and research, including clinical trials. It has as many as ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Peptinovo Biopharma, an Ann Arbor-based biotechnology company pioneering targeted cancer therapies through its first-of-its-kind proprietary PALM™ nanotechnology, today announced it has received ...

On January 9th, GENEIII reaffirmed its global leadership in ergothioneine production and scientific validation at the ...

The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not ...